HS Code Guide · Chapter 30
💊

HS Codes for Pharmaceuticals & Medicines

Medicines, vaccines, bandages and diagnostic reagents — Chapter 30 of the Harmonised System covers all pharmaceutical and veterinary products.

Chapter 30 of the Harmonised System covers pharmaceutical products — from finished medicaments (heading 3004) to blood fractions (heading 3002) to medical bandages (heading 3005) and diagnostic reagents (heading 3822). Pharmaceutical products are heavily regulated at both customs and regulatory levels. In the EU, a Marketing Authorisation (MA) from the EMA or national medicines authority is required before any medicine can be sold or distributed. Import of finished medicaments without proper authorisation is prohibited. Import duties on pharmaceuticals are generally 0% in the EU, UK and USA for most headings, but the regulatory barrier — not the duty — is the primary concern for pharmaceutical shippers.

Common HS Codes for Pharmaceuticals & Medicines

Import duty rates shown for the EU (from non-EU), UK (from non-UK), and USA (from non-USA). Intra-EU shipments have 0% duty.

HS CodeProduct descriptionEU dutyUK dutyUSA dutyNotes
3001.90.91Dried glands and other organs for organo-therapeutic uses0%0%0%Biological starting materials — requires import permits in most markets
3002.11.00Malaria diagnostic test kits0%0%0%IVD (in-vitro diagnostic) device — CE IVD marking required for EU
3002.12.00Antisera and other blood fractions0%0%0%Immunoglobulins, plasma — very strict import controls
3002.20.00Vaccines for human medicine0%0%0%Requires cold chain (2–8°C) and MA in destination country
3002.30.00Vaccines for veterinary medicine0%0%0%Veterinary vaccines — DEFRA (UK), USDA (USA) controls apply
3004.10.00Medicaments containing penicillin or streptomycin0%0%0%Antibiotic medicines — MA required, controlled substance rules may apply
3004.20.00Medicaments containing antibiotics (other)0%0%0%Other antibiotic finished dose forms
3004.50.90Medicaments containing vitamins (other)0%0%0%Vitamin supplement finished products — nutritional supplements may fall under food law instead of pharma
3004.90.00Other medicaments for therapeutic or prophylactic use NES0%0%0%Catch-all for finished dose form medicaments not elsewhere specified
3005.10.00Adhesive dressings and bandages with pharmaceutical substance0%0%0%Medicated wound dressings — may be classified as medical device
3005.90.99Other bandages, wadding, gauze (non-medicated)0%0%0%Basic wound care products
3822.11.00Diagnostic reagents on a backing (blood-glucose test strips)0%0%0%IVD — CE IVD EU Regulation 2017/746 applies from May 2022

Duty rates are indicative based on standard MFN (Most Favoured Nation) tariffs. Actual rates may vary by country of origin and applicable trade agreements. Always verify with the official tariff database of the destination country.

Import Duty Notes by Market

EU

Chapter 30 pharmaceutical products attract 0% MFN import duty across virtually all headings. This reflects the Pharmaceutical Tariff Elimination Agreement under WTO. However, duty is secondary to regulatory requirements — a Marketing Authorisation (MA) from EMA or national competent authority is mandatory for all finished medicaments placed on the EU market. IVD devices require CE IVD marking under EU Regulation 2017/746.

UK

UK applies 0% duty on Chapter 30 pharmaceuticals under the UK Global Tariff (mirroring WTO Pharma Agreement). Post-Brexit, the UK runs its own regulatory regime via MHRA (Medicines and Healthcare products Regulatory Agency). EU Marketing Authorisations are no longer valid in the UK — a separate MHRA authorisation is required. IVDs require UKCA marking since July 2023.

USA

USA applies 0% duty on most Chapter 30 headings under HTSUS. The FDA regulates pharmaceutical imports — all drug products must have an approved NDA (New Drug Application) or ANDA (generic). Personal use imports are subject to FDA personal importation policy (limited quantities, for personal use). Commercial import of unapproved drugs is prohibited.

Customs Tips for Pharmaceuticals & Medicines

Frequently Asked Questions

Can I ship medicines from Portugal to other countries?

Shipping finished medicaments internationally requires a Marketing Authorisation in the destination country. Within the EU, a centrally-authorised medicine (EMA approval) or nationally-authorised medicine can move between EU member states under certain conditions. Outside the EU (UK, USA, etc.), separate national authorisations are required. Personal use quantities may be exempt under some countries' personal importation policies, but commercial export always requires proper authorisation.

What is the HS code for vitamin supplements?

It depends on how the product is presented and labelled. Vitamin supplements presented as food (nutritional supplement with nutritional claims) are generally classified under Chapter 21 (9021.90.00 or 2106.90.xx). Vitamins presented as medicaments (making therapeutic claims) fall under Chapter 30 (3004.50.90). The packaging, labelling and intended use determine the classification — customs authorities in the destination country will examine the product's claims.

Do I need a special licence to export medicines from Portugal?

Yes — commercial export of medicinal products from Portugal requires a wholesale distribution authorisation from INFARMED (Portuguese national medicines and health products authority) and the medicine must hold a valid Marketing Authorisation in the destination country. For export outside the EU, a Certificate of a Pharmaceutical Product (CPP) from INFARMED may be required by the destination country's authorities.

What HS code covers COVID-19 test kits?

Rapid antigen COVID-19 test kits are classified under HS 3822 (diagnostic reagents). Specifically, lateral flow test kits typically use HS 3822.11.00 (diagnostic reagents on a backing). These are classified as IVD (in-vitro diagnostic) medical devices and require CE IVD marking for EU market access under EU Regulation 2017/746.

Are there import duties on pharmaceuticals in the EU?

No — virtually all Chapter 30 pharmaceutical products attract 0% MFN import duty in the EU under the WTO Pharmaceutical Tariff Elimination Agreement. The regulatory barrier (Marketing Authorisation) is the primary constraint on pharmaceutical trade, not import duties.

Related Guides

Ready to Ship? Compare Carrier Prices

Get instant quotes from DHL, UPS, FedEx, DPD and GLS — door-to-door with customs documentation support.

Get a Free Quote →